Expertise in
2
conditions

Richard K. Haynes

Old Road Campus, Roosevelt Drive, 
Oxford, ENG, GB 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Old Road Campus, Roosevelt Drive, 
Oxford, ENG, GB 

Overview

Richard Haynes practices practicing medicine in Oxford, United Kingdom.

Mr. Haynes is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Chronic Kidney Disease, Malaria, Type 2 Diabetes (T2D), Vitrectomy, and Kidney Transplant.

He is actively involved in clinical research, co-authoring 213 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Old Road Campus, Roosevelt Drive, Oxford, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Randomised Evaluation of COVID-19 Therapy
Randomised Evaluation of COVID-19 Therapy
Enrollment Status: Recruiting
Publish Date: January 05, 2024
Intervention Type: Drug, Biological
Study Drugs: Lopinavir, Ritonavir, Corticosteroid, Hydroxychloroquine, Azithromycin, Convalescent plasma, Tocilizumab, Immunoglobulin, Synthetic neutralising antibodies, Aspirin, Colchicine, Baricitinib, Anakinra, Dimethyl fumarate, Empagliflozin
Study Phase: Phase 3
StereoTactic Radiotherapy for Wet Age-Related Macular Degeneration (STAR): A Randomised, Double-masked, Sham-controlled, Clinical Trial Comparing Low-voltage X-ray Irradiation With as Needed Ranibizumab, to as Needed Ranibizumab Monotherapy.
StereoTactic Radiotherapy for Wet Age-Related Macular Degeneration (STAR): A Randomised, Double-masked, Sham-controlled, Clinical Trial Comparing Low-voltage X-ray Irradiation With as Needed Ranibizumab, to as Needed Ranibizumab Monotherapy.
Enrollment Status: Completed
Publish Date: August 06, 2025
Intervention Type: Drug, Radiation
Study Drug: Ranibizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

210 Total Publications

SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.
Journal: JAMA
Published: November 07, 2025

Frequently Asked Questions about Richard K. Haynes

Is Richard K. Haynes a top-rated expert for Vitrectomy?

MediFind is an objective health platform that identifies experts based on real-world data. Richard K. Haynes is classified as an Advanced expert for Vitrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Richard K. Haynes participate in research or clinical trials?

Yes. Richard K. Haynes has published 210 articles and abstracts on conditions like Vitrectomy. You can view a list of Richard K. Haynes's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Haynes's expertise for a condition
ConditionClose
      View All 25 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile